Schering-Plough agrees to wholesale fee-for-service
Executive Summary
Schering-Plough signs fee-for-service drug wholesale agreements with Cardinal, McKesson and AmerisourceBergen. Cardinal and McKesson have set a March 31 deadline for drug manufacturers to agree to distribution contracts following the new compensation model; Pfizer has declared it will not sign a fee-for-service agreement (1"The Pink Sheet" Jan. 24, 2005, p. 8)...
You may also be interested in...
Pfizer Says No To “Fee-For-Service” Contracts; Cardinal, Eisai Reach Deal
Pfizer is not involved in "fee-for-service" negotiations with wholesalers, the company declared in its fourth quarter earnings release Jan. 19
Sanofi Prepares Pulmonologists As Dupixent Nears COPD Finishing Line
The French drugmaker has identified education as a key challenge ahead of its June action date for the huge-selling IL4/IL-13 inhibitor in the lung condition. An approval would make it the first biologic for the disease.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.